Package of Spravato nasal spray with red and gray text, colorful rays design, and information about the medication being 28 mg of esketamine.
Healthcare informational poster explaining safety warnings for SPRAVATO medication, including potential side effects like sedation, dissociation, misuse, and abuse. The poster emphasizes consulting healthcare providers for serious side effects, monitoring after use, and reporting abuse or dependence issues.
Page from a safety information document discussing the risks and prevention of suicidal thoughts, including details about medication risks, warning signs, and when to seek immediate medical help.
Find A Prescriber
Find A Therapist
Spravato nasal spray device next to logo and name, 'Spravato (esketamine) nasal spray' with stylized burst graphic.

Spravato

We are happy to be able to provide you with SPRAVATO® (esketamine) CIII, a nasal spray that can be taken with an oral antidepressant to treat treatment-resistant depression (TRD) in adults and depressive symptoms in adults with MDD with acute suicidal ideation or behavior. 

Learn more

When deciding to explore mental health medications, you don’t have to make the decision alone.